Smilowska Katarzyna, Pietrzykowski Tomasz, Chaudhuri K Ray, Bloem Bastiaan R, Wamelen Daniel J van
Department of Neurology, 5th Regional Hospital, Sosnowiec, Poland.
Radboud University Medical Centre; Donders institute for Brain, Cognition and Behaviour; Department of Neurology; Centre of Expertise for Parkinson & Movement Disorders; Nijmegen, The Netherlands.
J Mov Disord. 2024 Apr;17(2):208-212. doi: 10.14802/jmd.23172. Epub 2023 Nov 20.
Access to care for people with Parkinson's disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation, intraduodenal levodopa pump therapy, and apomorphine pump therapy) in Poland.
We analyzed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015-2021.
In 2021, the number of persons receiving DAT in Poland was 0.56% of the total PD population, increasing from 0.21% in 2015. Overall, deep brain stimulation was the preferred DAT in Poland, but strong regional differences in the use of the other DATs were observed. Accessibility to DAT was negatively associated with average annual income (p < 0.001).
Access to DAT for persons with PD in Poland is still limited, and strong regional differences in accessibility were observed, although its general increase over the last decade is encouraging.
帕金森病（PD）患者获得医疗服务，尤其是器械辅助治疗（DAT）的机会分布不均。目的是分析波兰DAT（深部脑刺激、十二指肠内左旋多巴泵治疗和阿扑吗啡泵治疗）的可及性。
通过确定2015 - 2021年期间接受三种DAT之一的PD患者人数，分析波兰DAT的使用分布情况。
2021年，波兰接受DAT的人数占PD总人口的0.56%，高于2015年的0.21%。总体而言，深部脑刺激是波兰首选的DAT，但在其他DAT的使用上存在显著的地区差异。DAT的可及性与平均年收入呈负相关（p < 0.001）。
波兰PD患者获得DAT的机会仍然有限，尽管过去十年总体有所增加，但在可及性方面存在显著的地区差异。
